Clinical Support Foundation and HIRA Sign MOU for Big Data-Driven Clinical Applications

The National Clinical Trial Support Foundation and the Health Insurance Review and Assessment Service held a business agreement ceremony to establish a cooperative relationship for the utilization of healthcare big data. Bae Byeong-jun, Chairman of the National Clinical Trial Support Foundation (left), and Kim Seon-min, President of the Health Insurance Review and Assessment Service, are taking a commemorative photo. (Photo by National Clinical Trial Support Foundation)

[Asia Economy Reporter Chunhee Lee] The National Clinical Trial Support Foundation announced on the 16th that it signed a 'Memorandum of Understanding (MOU) for the Utilization of Healthcare Big Data and the Development of the Clinical Trial Industry' with the Health Insurance Review and Assessment Service (HIRA) at HIRA's headquarters in Wonju, Gangwon Province the day before.

Through this agreement, both organizations pledged cooperation in ▲analysis and utilization of healthcare big data ▲exchange of expertise and information ▲exchange of professionals and talent development.

The Clinical Trial Support Foundation is promoting the 'One-stop Smart Clinical Trial System Establishment' project to enhance domestic clinical capabilities and competitiveness and to respond to changes in the clinical paradigm. The four key focus areas are ▲establishment of a disease-specific patient matching platform ▲establishment of a national clinical trial big data center ▲dissemination and expansion of the national clinical trial management system ▲construction of a non-face-to-face clinical trial system.

Both organizations agreed to utilize HIRA's healthcare big data to strengthen the safety of clinical trial subjects. Through this, clinical trial subjects will have reduced unnecessary visits and be able to participate only in appropriate clinical trials, thereby enhancing safety. Researchers also benefit by reducing unnecessary tests and enabling the selection of suitable subjects. Additionally, they plan to continuously advance services to strengthen clinical trial subject safety, including systematic provision of health information to clinical trial subjects and proactive clinical trial subject matching.

Byunghun Bae, Chairman of the Clinical Trial Support Foundation, said, “Through this MOU, we will actively utilize healthcare big data to reduce clinical costs and time, and establish a system to discover and utilize real clinical evidence (RWE, Real World Evidence) to respond to changes in the global clinical environment.”

This content was produced with the assistance of AI translation services.